Resources from the same session
60O - A phase Ia study of DNP002, a monoclonal antibody that binds to tumor-associated CEACAM family proteins, in patients with advanced solid tumors: Interim results from dose escalation study
Presenter: Wonyoung Choi
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
61O - Updated results of a phase II trial evaluating an anti-EpCAM x anti-CD3 bispecific antibody, M701, for the treatment of malignant ascites
Presenter: Rongrui Liu
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Webcast
479MO - Erlotinib plus bevacizumab in patients with metastatic solid tumors with EGFR amplification: Results from the KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced solid tumors, KCSG AL 22-09)
Presenter: Ji Won Lee
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
480MO - Prevalence and characteristics of TP53 Y220C mutations in patients with solid malignancies
Presenter: Yostena Mekhail
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
481MO - Next-generation sequencing (NGS) of paired tumor tissue and blood samples from patients with advanced solid cancers: A complementary approach
Presenter: Nitesh Rohatgi
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
482MO - Clinical usefulness of next-generation sequencing for metastatic or unresectable gastric cancer in molecular profiling-guided therapy era
Presenter: Songji Choi
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
483MO - RNA-based multiplex polymerase chain reaction and sequencing to detect fusion genes in melanoma
Presenter: Tokimasa Hida
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract
Invited Discussant 482MO and 483MO
Presenter: David Thomas
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Slides
Webcast
Q&A and discussion
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Webcast